BRUSSELS, March 17, 2026 /PRNewswire/ -- Today, Advanced Biotech for Sustainability (AB4S), a cross-sector coalition that's committed to unlocking the full environmental potential of advanced biotechnology, published its second annual report, "The Molecule Manifesto: Four Priority Molecule Families to Unlock Industrial Biotech Scale." Following last year's quantification of a $1.1 trillion market opportunity, this new roadmap identifies the specific molecular "winners" ready for immediate commercial scale-up to meet global climate and supply chain goals.

While AB4S' inaugural report established the economic case for biotechnology, the 2026 report shifts from theory to execution. After evaluating over 300 molecules across 40 chemical families, the coalition has identified four priority families, terpenes, peptides, non-catalytic proteins, and hydroxy acids, as the most viable near-term opportunities for biobased production.
Key insights from the report include:
To translate this report's prioritization into commercial reality, AB4S calls for greater collaboration and investment in terpenes, peptides, non-catalytic proteins, and hydroxy acids—alongside targeted infrastructure investment and cross-sector collaboration to move these four molecule families from pilot to full industrial scale.
"AI is already delivering impressive results for top innovators around the world, bringing new molecules to market faster and at lower cost than ever before," said Stef van Grieken, CEO of AB4S member Cradle, an AI-powered protein design platform. "Sustainable materials represent a significant growth opportunity, and the nexus is right here in Europe. With strong support for sustainable materials and biotech across the region, plus a world-class labor pool, leaders who embrace these insights can power new industries that will unlock impressive benefits across society."
To download the full report, visit: https://www.ab4s.org/2026
About Advanced Biotech for Sustainability (AB4S)
Founded in 2025, the Advanced Biotech for Sustainability (AB4S) is a coalition of industry-leading organizations from across the ecosystem (including incumbent, start-up, scale-up and non-profit) that are committed to unlocking the full potential of advanced biotechnology through thought leadership, actionable recommendations and cross-industry collaboration. AB4S currently comprises 8 founding members, including Arsenale Bioyards, Cradle, Darwin International, EIT Food, Evonik, Lallemand, L'Oréal, and ShakeUp Factory. For more information on the coalition or to support its mission, visit www.ab4s.org.
Logo - https://mma.prnewswire.com/media/2846228/Cradle_Logo.jpg